Entellus Medical Inc. (ENTL)

24.00
0.01 0.04
NASDAQ : Health Technology
Prev Close 24.01
Open 24.00
Day Low/High 24.00 / 24.08
52 Wk Low/High 11.47 / 25.58
Volume 43.90K
Avg Volume 351.20K
Exchange NASDAQ
Shares Outstanding 25.65M
Market Cap 615.81M
EPS -1.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Entellus Medical Stock Sees Short Interest Drop 35.2%

The most recent short interest data has been released for the 01/31/2017 settlement date, which shows a 269,821 share decrease in total short interest for Entellus Medical Inc , to 497,448, a decrease of 35.17% since 01/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Oversold Conditions For Entellus Medical (ENTL)

Oversold Conditions For Entellus Medical (ENTL)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

National Institute For Health And Care Excellence (NICE) Provides Positive Guidance For Use Of The XprESS Multi-Sinus Dilation System For Treating Chronic Sinusitis

National Institute For Health And Care Excellence (NICE) Provides Positive Guidance For Use Of The XprESS Multi-Sinus Dilation System For Treating Chronic Sinusitis

Studies show treatment with XprESS Multi-Sinus Dilation System leads to a rapid and sustained improvement in chronic symptoms, fewer acute episodes, and improved quality of life

Entellus Medical Announces Publication Of Positive Clinical Data For XprESS For Treatment Of Pediatric Chronic Rhinosinusitis

Entellus Medical Announces Publication Of Positive Clinical Data For XprESS For Treatment Of Pediatric Chronic Rhinosinusitis

Pediatric Results Published in the International Forum of Allergy & Rhinology

Entellus Medical To Report Third Quarter 2016 Financial Results On November 3, 2016

Entellus Medical To Report Third Quarter 2016 Financial Results On November 3, 2016

Conference call scheduled for Thursday, November 3, 2016 at 3:30pm CT / 4:30pm ET

Insider Trading Alert - ENTL, AZZ And JCTCF Traded By Insiders

Insider Trading Alert - ENTL, AZZ And JCTCF Traded By Insiders

Stocks with insider trader activity include ENTL, AZZ and JCTCF

Entellus Medical To Report Second Quarter 2016 Financial Results On August 3, 2016

Entellus Medical To Report Second Quarter 2016 Financial Results On August 3, 2016

Conference call scheduled for Wednesday, August 3, 2016 at 3:30pm CT / 4:30pm ET

Entellus Medical And Fiagon Announce Expanded Agreement To Include Hospital-Based Customers

Entellus Medical And Fiagon Announce Expanded Agreement To Include Hospital-Based Customers

Introduction of the Premium Fiagon Navigation System for hospital customers, complete with more advanced ENT and cranio-maxillofacial (CMF) applications

Entellus Medical Announces Presentation Of Positive Clinical Study Results For XprESS In Pediatric Patients

Entellus Medical Announces Presentation Of Positive Clinical Study Results For XprESS In Pediatric Patients

Balloon Sinus Dilation Determined to be Safe and Effective for Children with CRS Aged Two Years and Older

Entellus Medical Enters Oversold Territory (ENTL)

Entellus Medical Enters Oversold Territory (ENTL)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Entellus Medical To Report First Quarter 2016 Financial Results On May 4, 2016

Entellus Medical To Report First Quarter 2016 Financial Results On May 4, 2016

Conference call scheduled for Wednesday, May 4, 2016 at 3:30pm CT / 4:30pm ET

Insider Trading Alert - EXLS, ENTL And GPRE Traded By Insiders

Insider Trading Alert - EXLS, ENTL And GPRE Traded By Insiders

Stocks with insider trader activity include EXLS, ENTL and GPRE

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CECO, CVCY, HCA, ISIL, KOSS, OB, ORCL, ORM, PJC, RGR, SFM, SUP Downgrades: CKH, CST, HBMD, HCCI, NLNK, NRG, OPK, SWIR, WABC Initiations: ENTL, TNET, VSTO, ZSAN Read on to get TheStreet Quant Ratings' detailed report:

Entellus Medical To Report Fourth Quarter And Year-End 2015 Financial Results On February 24, 2016

Entellus Medical To Report Fourth Quarter And Year-End 2015 Financial Results On February 24, 2016

Conference Call Scheduled for Wednesday, February 24, 2016 at 4:30pm ET

Entellus Medical is Now Oversold (ENTL)

Entellus Medical is Now Oversold (ENTL)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.